Netherlands· NL-3485607d4a38

Atofab 100 mg harde capsules

A atomoxetine product containing atomoxetinehydrochloride, registered in Netherlands by G.L. Pharma GmbH. The same ATC class is registered in 17 of our 19 countries.

ATC N06BA09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about atomoxetinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Atomoxetine is registered in 17 of 19 countries.

Countries holding a registration under ATC N06BA09 (atomoxetine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search atomoxetine products by name

Atomoxetine · ATC N06BA09

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of atomoxetine costs, country by country.

Normalised to the WHO defined daily dose (80 mg), the median price runs from $1.05 in United States to $9.70 in Switzerland — a ×9.2 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Atomoxetine · price per daily dose (80 mg)

USD · FX 28 Sept 2026

CH Switzerland$9.70
ES Spain$2.37
US United States$1.05 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ATOMOXETINEHYDROCHLORIDE
Manufacturer: G.L. Pharma GmbH
Country: Netherlands (NL)
ATC code: N06BA09
ATC class: Atomoxetine
Defined daily dose: 80 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
120978

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

275 interactions on record for atomoxetine.

Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check atomoxetine against other medicines How interaction checks work

Atomoxetine · interactions on record

275 records

50 severe
166 moderate
4 minor
54 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
PapaverinC04AX38severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Atomoxetine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atomoxetine products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Atofab, Atomoxetin Amarox
Belgium · Strattera
Bulgaria · Atofab
Cyprus · Strattera
Czechia · Atofab, Atominex
Germany · Agakalin, Atama
Denmark · Atomoxetin Amarox, Atomoxetin Glenmark
Estonia · Atominex
Spain · Atamax, Atomoxetina Aurovitas
Finland · Atomoxetin Orion, Atomoxetine Accord
United Kingdom (Northern Ireland) · Atomaid, Atomoxetine
Greece · Atama
Croatia · Attoxem
Hungary · Atomoxetin Amarox, Bitinex
Ireland · Atomoxetine Accord, Atomoxetine Azure
Iceland · Atomoxetin Actavis, Atomoxetin Medical Valley
Malta · Atomoxetina Generis, Atomoxetine Aurobindo
Norway · Atomoxetin Orion, Atomoxetine Accord
Poland · Atomoksetyna Medice, Auroxetyn
Portugal · Atomoxetina Generis, Atomoxetina Macleods
Romania · Atofab, Atomoxetin Accord
Sweden · Atomoxetin Actavis, Atomoxetin Amarox
Slovenia · Atomoksetin Accord, Strattera
Slovakia · Atofab, Atominex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/57a3291b-ee00-48b7-9940-6417a7022b13
GET /v1/drugs/57a3291b-ee00-48b7-9940-6417a7022b13?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120978_smpc_en.pdf",
  "strength": null,
  "atc_label": "Atomoxetine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120978",
  "excipients": [
    "AMMONIA (E 527)",
    "DIMETICON (E 900)",
    "GELATINE (E 441)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "NATRIUMLAURILSULFAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK GLAZE, GEDEELTELIJK VERESTERD",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)",
    "ZWARTE INKT"
  ],
  "substances": [
    "ATOMOXETINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120978_piluk.pdf",
  "authorised_at": "2018/04/25",
  "procedure_number": "NL/H/4032/007",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120978",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about atomoxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console